Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome

Blood (2021) 137 (23): 3251–3258.

https://doi.org/10.1182/blood.2020008835

Published: 2021

Includes: Supplemental data

Journal Articles

Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)

Blood (2016) 128 (22): 396.

https://doi.org/10.1182/blood.V128.22.396.396

Published: 2016

Journal Articles

Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study

Jeanette K Doorduijn, MD PhD, Monique C. Minnema, MD PhD, Marie Jose Kersten, MD PhD, Pieternella J Lugtenburg, MD PhD, Martin R. Schipperus, MD PhD, Marinus van Marwijk Kooy, MD PhD, Marius MacKenzie, MD PhD, Josée M Zijlstra, MD, Henriette W Berenschot, MD, M. R Schaafsma, MD PhD, Dana A Chitu, PhD, Hanneke C. Kluin-Nelemans, MD PhD

Blood (2015) 126 (23): 339.

https://doi.org/10.1182/blood.V126.23.339.339

Published: 2015

Journal Articles

Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma

Marcel Nijland, MD, Karin Boslooper, MD, Anke Van den Berg, PhD, Hanneke C. Kluin-Nelemans, MD PhD, Peter Joosten, MD, Huib Storm, MD PhD, Robby Kibbelaar, MD PhD, Gustaaf van Imhoff, MD PhD, Mels Hoogendoorn, MD PhD

Blood (2015) 126 (23): 1503.

https://doi.org/10.1182/blood.V126.23.1503.1503

Published: 2015

Journal Articles

Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial

Jason Gotlib, MD MS, Hanneke C. Kluin-Nelemans, MD PhD, Tracy I. George, MD, Cem Akin, MD PhD, Karl Sotlar, MD, Olivier Hermine, MD PhD, Farrukh Awan, MD MS, Elizabeth O Hexner, MD, Michael Mauro, MD, David Sternberg, MD PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, Eric Stanek, PharmD, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD

Blood (2014) 124 (21): 636.

https://doi.org/10.1182/blood.V124.21.636.636

Published: 2014

Journal Articles

A Cohort Study Of 15,912 Patients On The Long-Term Quality Of Vka Therapy After Extreme Overanticoagulation

Hilde A.M. Kooistra, MD, Nakisa Khorsand, PharmD, Hanneke C. Kluin-Nelemans, Nic J.G.M. Veeger, PhD, Margriet Piersma, MD, Karina Meijer, MD, PhD

Blood (2013) 122 (21): 2384.

https://doi.org/10.1182/blood.V122.21.2384.2384

Published: 2013

Journal Articles

Role Of High-Dose Cytarabine and Total Body Irradiation Conditioning before Autologous Stem Cell Transplantation In Mantle Cell Lymphoma - A Comparison Of Nordic MCL2, HOVON 45, and European MCL Younger Trials

Blood (2013) 122 (21): 3367.

https://doi.org/10.1182/blood.V122.21.3367.3367

Published: 2013

Journal Articles

B Cell Receptor with Variant Surface Isotypes Transduce Functional Signals by Elevating Phospho-ERK1/2 Levels in Hairy Cell Leukemia with Mutant BRAF

Nicola J Weston-Bell, PhD, Francesco Forconi, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Surinder S Sahota, PhD

Blood (2013) 122 (21): 1772.

https://doi.org/10.1182/blood.V122.21.1772.1772

Published: 2013

Journal Articles

Durable Responses and Improved Quality Of Life With Midostaurin (PKC412) In Advanced Systemic Mastocytosis (SM): Updated Stage 1 Results Of The Global D2201 Trial

Jason Gotlib, MD, Hanneke C. Kluin-Nelemans, MD, PhD, Tracy I. George, MD, Cem Akin, MD, PhD, Karl Sotlar, MD, Olivier Hermine, Farrukh Awan, MD, MS, Elizabeth Hexner, MD, Michael Mauro, MD, Rodica Morariu, MD, Margaret Squier, MD, PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, John Coombs, PharmD, MBA, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD

Blood (2013) 122 (21): 106.

https://doi.org/10.1182/blood.V122.21.106.106

Published: 2013

Journal Articles

Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma.

Eva Hoster, Wolfram Klapper, Andreas Rosenwald, MD, Heinz-Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Wolfgang Hiddemann, MD, PhD, Michael Unterhalt, Hanneke C. Kluin-Nelemans, Olivier Hermine, Martin Dreyling

Blood (2012) 120 (21): 2677.

https://doi.org/10.1182/blood.V120.21.2677.2677

Published: 2012

Journal Articles

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.

Karin Boslooper, Peter Joosten, MD, Nic J.G.M. Veeger, PhD, Robby Kibbelaar, MD, PhD, Eric van Roon, Sjoerd Hovenga, Gerhard Woolthuis, MD, Hanneke C. Kluin-Nelemans, Mels Hoogendoorn, MD, PhD

Blood (2012) 120 (21): 2642.

https://doi.org/10.1182/blood.V120.21.2642.2642

Published: 2012

Journal Articles

Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

André Wieringa, PharmD, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Tim Beerden, B.Sc, Huib Storm, PhD, Robby Kibbelaar, MD, PhD, Hanneke C. Kluin-Nelemans, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD, PhD

Blood (2012) 120 (21): 3656.

https://doi.org/10.1182/blood.V120.21.3656.3656

Published: 2012

Journal Articles

KIT Inhibitor Midostaurin in Patients with Advanced Systemic Mastocytosis: Results of a Planned Interim Analysis of the Global CPKC412D2201 Trial

Jason Gotlib, MD, MS, Hanneke C. Kluin-Nelemans, MD, PhD, Tracy I. George, MD, Cem Akin, MD, PhD, Karl Sotlar, MD, Olivier Hermine, MD, PhD, Farrukh Awan, MD, MS, Elizabeth Hexner, MD, Michael J. Mauro, MD, Rodica Morariu, MD, Margaret Squier, MD, PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD

Blood (2012) 120 (21): 799.

https://doi.org/10.1182/blood.V120.21.799.799

Published: 2012

Journal Articles

Hairy Cell Leukaemia Displaying Multiple Surface Immunoglobulin Isotypes Reveal a Functional B-Cell Receptor In Which Isotype Roles Differ

Nicola J Weston-Bell, PhD, Gavin Babbage, Francesco Forconi, Hanneke C. Kluin-Nelemans, Surinder S Sahota, PhD

Blood (2011) 118 (21): 1567.

https://doi.org/10.1182/blood.V118.21.1567.1567

Published: 2011

Journal Articles

Double-hit B-cell lymphomas

Sietse M. Aukema, Reiner Siebert, Ed Schuuring, Gustaaf W. van Imhoff, Hanneke C. Kluin-Nelemans, Evert-Jan Boerma, Philip M. Kluin

Blood (2011) 117 (8): 2319–2331.

https://doi.org/10.1182/blood-2010-09-297879

Published: 2011

Includes: Supplemental data

Journal Articles

The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non–mast cell lineage disease (SM-AHNMD)

Peter Valent, Michel Arock, Cem Akin, Wolfgang R. Sperr, Andreas Reiter, Karl Sotlar, Karin Hartmann, Tracy I. George, Knut Brockow, Hanneke C. Kluin-Nelemans, Jason Gotlib, Dean D. Metcalfe, Hans-Peter Horny

Blood (2010) 116 (5): 850–851.

https://doi.org/10.1182/blood-2010-05-285270

Published: 2010

Journal Articles

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Blood (2010) 115 (16): 3215–3223.

https://doi.org/10.1182/blood-2009-06-230250

Published: 2010

Includes: Supplemental data

Journal Articles

Confirmation of the Mantle Cell Lymphoma International Prognostic Index (MIPI) in An Independent Prospective Patient Cohort.

Eva Hoster, Joerg Hasford, Olivier Hermine, Hanneke C. Kluin-Nelemans, Jan Walewski, Marek Trneny, Christian H. Geisler, Vincent Ribrag, Achiel Van Hoof, Wolfram Klapper, Wolfgang Hiddemann, Martin H. Dreyling, Michael Unterhalt

Blood (2009) 114 (22): 138.

https://doi.org/10.1182/blood.V114.22.138.138

Published: 2009

Journal Articles

Associations Between Free Protein S and Factor VIII Levels with Traditional Arterial Thrombotic Risk Factors and Their Risk On Arterial Thrombosis. Results From a Retrospective Family Cohort Study.

René Mulder, Inge M van Schouwenburg, Bakhtawar Khan Mahmoodi, Nic J.G.M. Veeger, André B Mulder, MD, Saskia Middeldorp, MD, PhD, Hanneke C. Kluin-Nelemans, Willem M Lijfering, MD

Blood (2009) 114 (22): 25.

https://doi.org/10.1182/blood.V114.22.25.25

Published: 2009

Journal Articles

A Low Wells Score in a Hospital Setting May No Longer Safely Rule out Deep Vein Thrombosis: Preliminary Results From a Single-Center Prospective University-Hospital Study Involving 227 Patients.

Ynse IGV Tichelaar, MD, Karina Meijer, MD, PhD, Jan ter Maaten, MD, PhD, Matthijs Oudkerk, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Willem M. Lijfering, MD, PhD

Blood (2009) 114 (22): 2469.

https://doi.org/10.1182/blood.V114.22.2469.2469

Published: 2009

NARROW

LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome

Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)

Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study

Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma

Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial

A Cohort Study Of 15,912 Patients On The Long-Term Quality Of Vka Therapy After Extreme Overanticoagulation

Role Of High-Dose Cytarabine and Total Body Irradiation Conditioning before Autologous Stem Cell Transplantation In Mantle Cell Lymphoma - A Comparison Of Nordic MCL2, HOVON 45, and European MCL Younger Trials

B Cell Receptor with Variant Surface Isotypes Transduce Functional Signals by Elevating Phospho-ERK1/2 Levels in Hairy Cell Leukemia with Mutant BRAF

Durable Responses and Improved Quality Of Life With Midostaurin (PKC412) In Advanced Systemic Mastocytosis (SM): Updated Stage 1 Results Of The Global D2201 Trial

Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma.

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.

Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

KIT Inhibitor Midostaurin in Patients with Advanced Systemic Mastocytosis: Results of a Planned Interim Analysis of the Global CPKC412D2201 Trial

Hairy Cell Leukaemia Displaying Multiple Surface Immunoglobulin Isotypes Reveal a Functional B-Cell Receptor In Which Isotype Roles Differ

Double-hit B-cell lymphomas

The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non–mast cell lineage disease (SM-AHNMD)

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Confirmation of the Mantle Cell Lymphoma International Prognostic Index (MIPI) in An Independent Prospective Patient Cohort.

Associations Between Free Protein S and Factor VIII Levels with Traditional Arterial Thrombotic Risk Factors and Their Risk On Arterial Thrombosis. Results From a Retrospective Family Cohort Study.

A Low Wells Score in a Hospital Setting May No Longer Safely Rule out Deep Vein Thrombosis: Preliminary Results From a Single-Center Prospective University-Hospital Study Involving 227 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only